Boston University (BU) School of Medicine — Boston, Massachusetts

Boston University (BU) School of Medicine is a clinical research site located in Boston, Massachusetts, United States 02118.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Boston University (BU) School of Medicine has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis.

Sponsors: Eidos Therapeutics, a BridgeBio company.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Boston University (BU) School of Medicine?

Boston University (BU) School of Medicine has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Boston University (BU) School of Medicine conducted?

Boston University (BU) School of Medicine has 1 clinical trials on record, with 1 currently active. Their work covers Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis.

Is Boston University (BU) School of Medicine accredited by Crixeo Health?

Boston University (BU) School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Boston University (BU) School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.